James A. Geraghty, Director at Voyager Therapeutics, Inc. (VYGR), bought 3,000 shares at $19.39 ($58K) on 2018-09-10, disclosed to the SEC on 2018-09-12.
Open-market purchase of $58k VYGR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| IDRA | BUY | 2018-08-08 | $56K | — | Filing → |
| PIRS | BUY | 2018-05-16 | $58K | — | Filing → |
| PIRS | BUY | 2017-08-17 | $48K | — | Filing → |